GAPDH

   Glyceraldehyde-3-phosphate dehydrogenase 

  • Alias                                 (According to NCBI)

 

  • HGNC:4141, 3' end
  • G3PD
  • G3PDH
  • GAPDH
  • glyceraldehyde-3-phosphate dehydrogenase .
  • Glyceraldehyde-3-phosphate dehydrogenase, liver (EC 1.2.1.12) (GAPDH).
  • Glyceraldehyde-3-phosphate dehydrogenase, muscle (EC 1.2.1.12) (GAPDH).
  • Glyceraldehyde-3-phosphate dehydrogenase catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The enzyme exists as a tetramer of identical chains. A GAPD pseudogene has been mapped to Xp21-p11 and 15 GAPD-like loci have been identified

 

  • Location: 12p13
  • Orientation: plus strand
  • Size: 3,879 bases
  • 9  exons
  • DNA sequence (Human): NC_000002

 

  • CGH (12p13) : Losses (%)  -3.9 Gain (%)  10.1 
  • Mutations and SNPs (According to HGMD and SNP)

 

  • m-RNA                       (According to NCBI and CGAP)

 

  • mRNA sequence (Human): NM_002046
  • size :1283 bp
  • cDNA Libraries : GAPD
  • Size: 334 amino acids; 35876 Da
  • Catalytic activity: D-glyceraldehyde 3-phosphate + phosphate + NAD+ = 3-phospho-D-glyceroyl phosphate + NADH.
  • Subcellular location: Cytoplasmic

  • Protein domains

 

 

                                   

 

  • Pathways and interactions (According to BioCarta, DIP)
  • Pathways

         Downregulated of MTA-3 in ER-negative Breast Tumors

 

          Glycolysis Pathway   

 

  • Protein interactions:

 

 
  • Clinical                            (According to OMIM, PubMed)